Carillon Tower Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$186M Buy
2,543,104
+1,033,375
+68% +$76.8M 1.13% 7
2020
Q3
$117M Sell
1,509,729
-900,861
-37% -$62M 1.56% 2
2020
Q2
$134M Buy
2,410,590
+794,796
+49% +$34M 1.03% 8
2020
Q1
$48.6M Buy
1,615,794
+414,850
+35% +$14M 0.48% 55
2019
Q4
$43.5M Sell
1,200,944
-604,942
-33% -$18.5M 0.29% 121
2019
Q3
$49.2M Hold
1,805,886
0.34% 98
2019
Q2
$43.4M Hold
1,805,886
0.3% 117
2019
Q1
$47.7M Hold
1,805,886
0.34% 104
2018
Q4
$35.3M Hold
1,805,886
0.3% 124
2018
Q3
$35.4M Hold
1,805,886
0.25% 160
2018
Q2
$29.9M Buy
+1,805,886
New +$27.5M 0.24% 153

Other funds holding HZNP